POLISCOPE
Back to feed
HR8323FEDERALIN_COMMITTEE
High Impact

Comprehensive Addiction Resources Emergency Act of 2024

May 17, 2024

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

Where This Stands

Introduced
Committee
Floor Vote
Passed
Signed

Currently IN_COMMITTEE. The next step in the legislative lifecycle is Floor Vote.

Version history

Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.

View official text →

The Frame

What this does

If passed, this bill would authorize $5.3 billion annually through 2033 to expand access to addiction treatment, mental health services, and overdose reversal drugs for individuals and families struggling with substance use disorders.

Who is mentioned in the record

Potentially affected actors named in the source documents. Mention is not a position.

Individuals with substance use disorder

They are the primary recipients of the expanded treatment, harm reduction, and recovery services funded by the bill.

State and local governments

They are eligible to apply for and administer federal grants to address substance use in their jurisdictions.

Indian tribes

They are eligible for specific formula grants and are consulted on the development of tribal-specific eligibility and allocation criteria.

Drug manufacturers and distributors

They must comply with new annual certification requirements regarding diversion controls and misbranding of Schedule II substances.

Labor unions

Grant recipients are required to prioritize funding for entities that have collective bargaining agreements or policies supporting labor organizing.

What changed

Current stage: IN_COMMITTEE.

What's next

Floor Vote.

Summary

This bill creates a massive federal grant program to provide emergency funding to states, tribal nations, and local areas for substance use disorder treatment, prevention, and . It also mandates new annual certifications for drug manufacturers and distributors to prevent the of controlled substances and establishes a new fund for addiction resources.

Key Facts

You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.

Why It Matters

If passed, this bill would authorize $5.3 billion annually through 2033 to expand access to addiction treatment, mental health services, and overdose reversal drugs for individuals and families struggling with substance use disorders.

Frequently Asked Questions

Who is eligible to receive these grants?
Eligible entities include states, territories, tribal nations, local areas (cities/counties), public or private nonprofit entities, and certain Medicaid providers.
Can these funds be used for involuntary treatment?
No. The bill explicitly prohibits using funds for the incarceration, institutionalization, or involuntary treatment of individuals.
What are the new requirements for drug companies?
Manufacturers, distributors, and dispensers of s must submit annual certifications to the Attorney General confirming they have effective controls against drug and are reporting suspicious orders.

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Sponsors

Discoveries

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift90% confidence

Labor-Linked Funding

The bill introduces a novel requirement for grant recipients to prioritize entities with collective bargaining agreements or explicit labor-organizing protections, linking public health funding to labor policy.

Analysis Score

0–100
  • Significance90
    How much this matters to a regular citizen
  • Controversy40
    Intensity of disagreement among stakeholders
  • Entertainment10
    Compellingness for a non-policy-wonk reader
  • Buzz60
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record